Digital breast tomosynthesis cuts recall rates by 40 percent

Adding digital breast tomosynthesis to 2D mammography screening results in a 40% reduction in patient recall rates compared to routine screening mammography alone, a new study shows.

The study, conducted at Yale University School of Medicine in New Haven, CT, of 7,578 , found that the recall rate was 6.6% for digital breast tomosynthesis plus 2D screening mammography. It was 11.1% for 2D screening mammography alone, said Melissa Durand, MD, one of the authors of the study.

Similar recall rates were seen in both groups for masses, but the recall rate was significantly lower with digital breast tomosynthesis and 2D mammography compared to 2D mammography alone for asymmetries and calcifications, said Dr. Durand. The recall rate was 2.8% for asymmetries when both techniques were used compared to 7.1% for routine screening mammography, she said. "Tomosynthesis, which is 3D mammography, allows us to look at the breast in 1 mm slices. In routine mammography, is compressed and overlying tissue can look like a suspicious finding. Tomosynthesis resolves this by looking slice by slice," said Liane Philpotts, MD, a study author.

The for the combined examination is below the Food and Drug Administration limit for mammography and below the dose of film mammography, noted Dr. Durand. "For now we are doing both examinations, but it may not be long before we will be able to do just the tomosynthesis exam. Researchers are working on ways to get a 2D image out of the 3D data, and when that happens, there may be no need for the 2D examination," Dr. Philpotts said.

"Recalls from screening incite considerable anxiety in women. With digital breast tomosynthesis, we are seeing a dramatic reduction in our recall rates which helps lessen our patients' anxiety. Fewer recalls means fewer additional views, which is cost saving and may also reduce overall annual radiation dose," said Dr. Durand.

add to favorites email to friend print save as pdf

Related Stories

3D technology takes next step beyond traditional mammography

Apr 20, 2012

MILWAUKEE - After already having been through breast cancer treatment, Michelle Luckiesh did not think twice when doctors at Waukesha Memorial Hospital told her they had a new mammography device that may be able to detect ...

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

Nov 21, 2014

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

Nov 21, 2014

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.